YNYouguo Niu

Youguo Niu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Youguo Niu has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maternal cardiometabolic dysfunction and fetal sex‐specific alterations to uterine vascular reactivity in an ovine model of obesity during pregnancy

    by Rachael C. Crew, Anna L. K. Cochrane, Youguo Niu, Sage G. Ford, Clement L. R. Cahen, Skaai H. Davison, Michael P. Murphy, Susan E. Ozanne, Dino A. Giussani

    Obesity during pregnancy is at pandemic proportions and predisposes women to pre‐ and postnatal cardiovascular dysfunction. The mechanisms underlying this maternal cardiovascular vulnerability remain unclear, partly due to a lack of translatable models capable of longitudinal in vivo cardiovascular monitoring. Here, we characterize a novel ovine model of maternal diet‐induced obesity during pregnancy. Ewes were fed a control (CON) or obesogenic (OB; ad libitum concentrates) diet for 60 days pre‐pregnancy and throughout gestation. Pregnant ewes were surgically instrumented with vascular catheters and Transonic flow probes using the wireless CamDAS system, which measured maternal cardiovascular function near term in free‐moving ewes. Uterine artery vasoreactivity was assessed ex vivo by in vitro wire myography. OB ewes entered pregnancy 30% heavier than controls ( P < 0.003) and were hyperglycaemic, hyperinsulinaemic and hyperlipidaemic during pregnancy, relative to CON ewes (all P < 0.05). OB ewes had elevated haematocrit and haemoglobin across pregnancy, and were hypertensive near term, with an increase in basal femoral artery blood flow, and elevated peripheral oxygen and glucose delivery (all P < 0.05). OB mothers carrying a female fetus showed increased uterine artery vascular resistance in vivo ( P < 0.005) and reduced smooth muscle‐dependent vasorelaxation ex vivo ( P < 0.05) relative to CON. Conversely, OB mothers carrying a male fetus showed greater NO‐independent mechanisms mediating the uterine vasodilator response to methacholine ex vivo ( P < 0.001). Collectively, this study characterizes a robust model of maternal obesity during pregnancy that offers clinical translational potential and highlights fetal sex‐specific changes to uterine artery function. image Key points: Obesity during pregnancy is increasingly common and predisposes women to cardiovascular dysfunction during pregnancy and long after birth, but the specific mechanisms underlying this remain unclear. We developed a novel ovine model of diet‐induced obesity during pregnancy that displays maternal hypertension, elevated haemoglobin, metabolic dysfunction, and alterations in uterine and peripheral blood flow and nutrient delivery near term. Mothers with obesity carrying a female fetus had elevated uterine vascular resistance in vivo and reduced uterine artery smooth muscle‐dependent vasodilator reactivity ex vivo . Mothers with obesity carrying a male fetus showed no effect on uterine vascular resistance in vivo , but greater NO‐independent mechanisms mediating the uterine vasodilator response to methacholine ex vivo . These findings highlight that fetal sex may influence maternal cardiovascular function during obese pregnancy.


  • Open Access

    Translatable in‐vivo investigation of effects of progressive hypoxia in pregnancy on fetal cardiac structure and function in sheep

    by O. V. Patey, K. J. Botting‐Lawford, Y. Niu, L. Zhang, J. Ma, S. G. Ford, W. Tong, C. M. Coutinho, B. Thilaganathan, D. A. Giussani

    Objective: Human fetal growth restriction (FGR) is associated with cardiac dysfunction. However, it remains unclear whether alterations in the fetal heart in human pregnancy affected by FGR are a consequence of chronic fetal hypoxia. In this study, we used novel in‐vivo ultrasound imaging modalities in pregnant sheep to evaluate fetal cardiac responses to progressive hypoxia in late gestation. Methods: This was a prospective study of data collected between July 2019 and March 2022 from 42 Welsh mountain ewes, each carrying a single fetus. Seventeen ewes were exposed to hypoxia in isobaric chambers (10% oxygen (O 2 )) from 105 days of gestational age (dGA; with term being approximately 147 days) for 11 ± 1 days (H1, n = 5), 17 ± 1 days (H2, n = 6) or 32 ± 2 days (H3, n = 6). An ultrasound system with vendor‐specific software was used to determine fetal left ventricular (LV) and right ventricular (RV) geometry and function. Outcomes were compared with the remaining 25 gestational age‐matched ovine normoxic control pregnancies at 117 ± 1 (N1, n = 13), 124 ± 1 (N2, n = 5) and 133 ± 3 (N3, n = 7) dGA. Results: Compared to controls with expected fetal RV dominance in late gestation, hypoxic fetal sheep showed LV dominance with increasing duration of hypoxia, including statistically significant increases in mean ± SD LV/RV end‐diastolic area ratio (N1, 1.1 ± 0.2 vs H1, 1.3 ± 0.1; N2, 1.2 ± 0.4 vs H2, 1.7 ± 0.5; N3, 0.9 ± 0.1 vs H3, 1.4 ± 0.2), LV sphericity index (N3, 0.44 ± 0.04 vs H3, 0.54 ± 0.11) and LV/RV cardiac output ratio (N1, 0.55 ± 0.18 vs H1, 1.00 ± 0.31; N2, 0.80 ± 0.10 vs H2, 1.62 ± 0.59; N3, 0.74 ± 0.23 vs H3, 1.50 ± 0.58). The mean ± SD LV myocardial performance index was significantly greater in the hypoxic groups, signifying global myocardial dysfunction (N1, 0.45 ± 0.07 vs H1, 0.64 ± 0.07; N2, 0.40 ± 0.05 vs H2, 0.66 ± 0.07; N3, 0.36 ± 0.07 vs H3, 0.60 ± 0.10). While LV apical radial strain and LV apical systolic rotation were initially increased after 17 days of hypoxia, these indices were significantly reduced after 32 days of hypoxia (median LV apical radial strain: N1, 27% (interquartile range (IQR), 26–28%) vs H1, 24% (IQR, 21–26%); N2, 24% (IQR, 22–25%) vs H2, 70% (IQR, 66–79%); N3, 51% (IQR, 48–54%) vs H3, 29% (IQR, 27–32%); mean ± SD LV apical systolic rotation: N1, 7 ± 5° vs H1, 5 ± 3°; N2, 9 ± 1° vs H2, 14 ± 2°; N3, 15 ± 2° vs H3, 7 ± 2°). Hypoxic fetuses showed biventricular hypertrophy and evidence of biventricular diastolic dysfunction, with significant LV impairment presenting after 11 days of hypoxia (mean ± SD LV isovolumetric relaxation time (IVRT′) normalized by cardiac cycle (cc) length: N1, 0.10 ± 0.02 ms vs H1, 0.15 ± 0.02 ms; N2, 0.09 ± 0.01 ms vs H2, 0.14 ± 0.02 ms; N3, 0.08 ± 0.03 ms vs H3, 0.12 ± 0.02 ms), preceding RV impairment after 32 days of chronic hypoxia (mean ± SD RV‐IVRT′ normalized by cc length: N3, 0.08 ± 0.03 ms vs H3, 0.14 ± 0.03 ms). Conclusions: Progressive fetal hypoxia in sheep leads to profound changes in fetal cardiac structure and function, resulting from a switch to LV dominance triggered by fetal brain sparing. The findings also indicate that fetal cardiac compensatory reserves become exhausted with progressive hypoxia. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


  • Open Access

    Hypoxic pregnancy promotes fibrosis and increases stress metabolites in the ovine fetal liver

    by Molly M. McGuckin, Dong Wang, Jasmine Ortiz, Evgenia Dobrinskikh, Wen Tong, Kimberley J. Botting‐Lawford, Youguo Niu, Dino A. Giussani, Stephanie R. Wesolowski

    Fetal chronic hypoxia is a common pregnancy complication associated with fetal growth restriction. Growth‐restricted offspring have a higher risk for liver metabolic disease. Our objective was to better understand how chronic hypoxia impacts the developing fetal liver. We hypothesized that hypoxia promotes hepatocellular injury, shifts nutrient metabolism, and activates energetic and oxidative stress in the fetal liver. We used an ovine model of chronic hypoxia where pregnant ewes were housed under normoxic (CON) or hypoxic (HOX) conditions for 30 days in late gestation. Fetal liver was obtained, histologically analysed and profiled using bulk‐RNA sequencing and metabolomics. Nutrient and oxidative stress signalling pathways were also measured. HOX fetuses had greater hepatic periportal collagen deposition. Metabolomics and transcriptomics predicted disruptions in central carbon metabolism, mitochondrial dysfunction and decreased oxidative phosphorylation. In support, we found potentiation of the gluconeogenic pathway and increased lactate production, pyruvate oxidation and AMPK activation. By contrast to the predicted effects, hypoxic livers maintained mitochondrial oxidation and antioxidant capacity. Interestingly, acylcarnitines were increased, yet hepatic triglyceride content was similar. Although there was little activation of oxidative stress markers, such as lipid peroxidation or oxidized glutathione, we uncovered a unique profile of liver stress‐related metabolites in association with periportal collagen. Thus, hypoxic pregnancy increased fetal hepatic collagen deposition, indicating liver injury, in association with a unique profile of liver stress metabolites and adaptations in central carbon metabolism. These results provide new insight into how chronic fetal hypoxia may initiate fibrotic and metabolic liver disease risk in offspring of adverse pregnancy. image Key points: Chronic exposure to hypoxic pregnancy increased fetal hepatic collagen deposition, indicating hepatocellular injury. Hypoxic fetal livers had a unique profile of stress metabolites and adaptations in central carbon metabolism. This provides new insight into how hypoxia, a common pregnancy complication associated with fetal growth restriction, may initiate fibrotic and metabolic liver disease risk.


  • Open Access

    Placental mitochondrial metabolic adaptation maintains cellular energy balance in pregnancy complicated by gestational hypoxia

    by Wen Tong, Beth J. Allison, Kirsty L. Brain, Olga V. Patey, Youguo Niu, Kimberley J. Botting, Sage G. Ford, Tess A. Garrud, Peter F. B. Wooding, Qiang Lyu, et al.

    The mechanisms that drive placental dysfunction in pregnancies complicated by hypoxia and fetal growth restriction remain poorly understood. Changes to mitochondrial respiration contribute to cellular dysfunction in conditions of hypoxia and have been implicated in the pathoaetiology of pregnancy complications, such as pre‐eclampsia. We used bespoke isobaric hypoxic chambers and a combination of functional, molecular and imaging techniques to study cellular metabolism and mitochondrial dynamics in sheep undergoing hypoxic pregnancy. We show that hypoxic pregnancy in sheep triggers a shift in capacity away from β‐oxidation and complex I‐mediated respiration, while maintaining total oxidative phosphorylation capacity. There are also complex‐specific changes to electron transport chain composition and a switch in mitochondrial dynamics towards fission. Hypoxic placentas show increased activation of the non‐canonical mitochondrial unfolded protein response pathway and enhanced insulin like growth factor 2 signalling. Combined, therefore, the data show that the hypoxic placenta undergoes significant metabolic and morphological adaptations to maintain cellular energy balance. Chronic hypoxia during pregnancy in sheep activated placental mitochondrial stress pathways, leading to alterations in mitochondrial respiration, mitochondrial energy metabolism and mitochondrial dynamics, as seen in the placenta of women with pre‐eclampsia. image Key points: Hypoxia shifts mitochondrial respiration away from β‐oxidation and complex I. Complex‐specific changes occur in the electron transport chain composition. Activation of the non‐canonical mitochondrial unfolded protein response pathway is heightened in hypoxic placentas. Enhanced insulin like growth factor 2 signalling is observed in hypoxic placentas. Hypoxic placentas undergo significant functional adaptations for energy balance.


  • Open Access

    Maladaptive cardiomyocyte calcium handling in adult offspring of hypoxic pregnancy: protection by antenatal maternal melatonin

    by Mitchell C. Lock, Olga V. Patey, Kerri L. M. Smith, Youguo Niu, Ben Jaggs, Andrew W. Trafford, Dino A. Giussani, Gina L. J. Galli

    Chronic fetal hypoxia is one of the most common complications of pregnancy and can programme cardiac abnormalities in adult offspring including ventricular remodelling, diastolic dysfunction and sympathetic dominance. However, the underlying mechanisms at the level of the cardiomyocyte are unknown, preventing the identification of targets for therapeutic intervention. Therefore, we aimed to link echocardiographic data with cardiomyocyte function to reveal cellular mechanism for cardiac dysfunction in rat offspring from hypoxic pregnancy. Further, we investigated the potential of maternal treatment with melatonin as antenatal antioxidant therapy. Wistar rats were randomly allocated into normoxic (21% O2) or hypoxic (13% O2) pregnancy with or without melatonin treatment (5 µg/ml; normoxic melatonin in the maternal drinking water from gestational day 6 to 20 (term = 22 days). After delivery, male and female offspring were maintained to adulthood (16 weeks). Cardiomyocytes were isolated from the left and right ventricles, and calcium (Ca2+) handling was investigated in field‐stimulated myocytes. Systolic and diastolic function was negatively impacted in male and female offspring of hypoxic pregnancy demonstrating biventricular systolic and diastolic dysfunction and compensatory increases in cardiac output. Ca2+ transients from isolated cardiomyocytes in offspring of both sexes in hypoxic pregnancy displayed diastolic dysfunction with a reduced rate of [Ca2+]i recovery. Cardiac and cardiomyocyte dysfunction in male and female adult offspring was ameliorated by maternal antenatal treatment with melatonin in hypoxic pregnancy. Therefore, cardiomyocyte Ca2+ mishandling provides a cellular mechanism explaining functional deficits in hearts of male and female offspring in pregnancies complicated by chronic fetal hypoxia. image Key points: This study identified significant changes in Ca2+ handling within cardiomyocytes isolated from offspring of hypoxic pregnancy including reduced systolic Ca2+ transients, impaired diastolic recovery of [Ca2+]i and a greater increase in systolic [Ca2+]i amplitude to β‐adrenergic stimulation. These changes in cardiomyocyte Ca2+ handling help to explain dysregulation of biventricular systolic and diastolic dysfunction determined by echocardiography. The data show protection against maladaptive cardiomyocyte calcium handling and thereby improvement in cardiac function in adult offspring of hypoxic pregnancy treated with melatonin with doses lower than those recommended for overcoming jet lag in humans. Melatonin treatment alone in healthy pregnancy did cause some alterations in cardiac structure. Therefore, maternal treatment with melatonin should only be given to pregnancies affected by chronic fetal hypoxia.


  • Open Access

    In vivo mitochondria‐targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy

    by Zhongchao Wang, Emily J. Camm, Anna Maria Nuzzo, Ana‐Mishel Spiroski, Katie L. Skeffington, Thomas J. Ashmore, Alessandro Rolfo, Tullia Todros, Angela Logan, Jin Ma, et al.

    Gestational hypoxia adversely affects uterine artery function, increasing complications. However, an effective therapy remains unidentified. Here, we show in rodent uterine arteries that hypoxic pregnancy promotes hypertrophic remodelling, increases constrictor reactivity via protein kinase C signalling, and triggers compensatory dilatation via nitric oxide‐dependent mechanisms and stimulation of large conductance Ca2+‐activated K+‐channels. Maternal in vivo oral treatment with the mitochondria‐targeted antioxidant MitoQ in hypoxic pregnancy normalises uterine artery reactivity and prevents vascular remodelling. From days 6–20 of gestation (term ∼22 days), female Wistar rats were randomly assigned to normoxic or hypoxic (13–14% O2) pregnancy ± daily maternal MitoQ treatment (500 µm in drinking water). At 20 days of gestation, maternal, placental and fetal tissue was frozen to determine MitoQ uptake. The uterine arteries were harvested and, in one segment, constrictor and dilator reactivity was determined by wire myography. Another segment was fixed for unbiased stereological analysis of vessel morphology. Maternal administration of MitoQ in both normoxic and hypoxic pregnancy crossed the placenta and was present in all tissues analysed. Hypoxia increased uterine artery constrictor responses to norepinephrine, angiotensin II and the protein kinase C activator, phorbol 12,13‐dibutyrate. Hypoxia enhanced dilator reactivity to sodium nitroprusside, the large conductance Ca2+‐activated K+‐channel activator NS1619 and ACh via increased nitric oxide‐dependent mechanisms. Uterine arteries from hypoxic pregnancy showed increased wall thickness and MitoQ treatment in hypoxic pregnancy prevented all effects on uterine artery reactivity and remodelling. The data support mitochondria‐targeted therapy against adverse changes in uterine artery structure and function in high‐risk pregnancy. image Key points: Dysfunction and remodelling of the uterine artery are strongly implicated in many pregnancy complications, including advanced maternal age, maternal hypertension of pregnancy, maternal obesity, gestational diabetes and pregnancy at high altitude. Such complications not only have immediate adverse effects on the growth of the fetus, but also they can also increase the risk of cardiovascular disease in the mother and offspring. Despite this, there is a significant unmet clinical need for therapeutics that treat uterine artery vascular dysfunction in adverse pregnancy. Here, we show in a rodent model of gestational hypoxia that in vivo oral treatment of the mitochondria‐targeted antioxidant MitoQ protects against uterine artery vascular dysfunction and remodelling, supporting the use of mitochondria‐targeted therapy against adverse changes in uterine artery structure and function in high‐risk pregnancy.


  • Open Access

    MitoQ as an antenatal antioxidant treatment improves markers of lung maturation in healthy and hypoxic pregnancy

    by Mitchell C. Lock, Kimberley J. Botting, Beth J. Allison, Youguo Niu, Sage G. Ford, Michael P. Murphy, Sandra Orgeig, Dino A. Giussani, Janna L. Morrison

    Chronic fetal hypoxaemia is a common pregnancy complication that increases the risk of infants experiencing respiratory complications at birth. In turn, chronic fetal hypoxaemia promotes oxidative stress, and maternal antioxidant therapy in animal models of hypoxic pregnancy has proven to be protective with regards to fetal growth and cardiovascular development. However, whether antenatal antioxidant therapy confers any benefit on lung development in complicated pregnancies has not yet been investigated. Here, we tested the hypothesis that maternal antenatal treatment with MitoQ will protect the developing lung in hypoxic pregnancy in sheep, a species with similar fetal lung developmental milestones as humans. Maternal treatment with MitoQ during late gestation promoted fetal pulmonary surfactant maturation and an increase in the expression of lung mitochondrial complexes III and V independent of oxygenation. Maternal treatment with MitoQ in hypoxic pregnancy also increased the expression of genes regulating liquid reabsorption in the fetal lung. These data support the hypothesis tested and suggest that MitoQ as an antenatal targeted antioxidant treatment may improve lung maturation in the late gestation fetus. image Key points: Chronic fetal hypoxaemia promotes oxidative stress, and maternal antioxidant therapy in hypoxic pregnancy has proven to be protective with regards to fetal growth and cardiovascular development. MitoQ is a targeted antioxidant that uses the cell and the mitochondrial membrane potential to accumulate within the mitochondria. Treatment of healthy or hypoxic pregnancy with MitoQ, increases the expression of key molecules involved in surfactant maturation, lung liquid reabsorption and in mitochondrial proteins driving ATP synthesis in the fetal sheep lung. There were no detrimental effects of MitoQ treatment alone on the molecular components measured in the present study, suggesting that maternal antioxidant treatment has no effect on other components of normal maturation of the surfactant system.


  • Open Access

    Molecular mechanisms underlying adverse effects of dexamethasone and betamethasone in the developing cardiovascular system

    by Tessa A. C. Garrud, Noor E. W. D. Teulings, Youguo Niu, Katie L. Skeffington, Christian Beck, Nozomi Itani, Fiona G. Conlon, Kimberley J. Botting, Lisa M. Nicholas, Wen Tong, et al.

    Antenatal glucocorticoids accelerate fetal lung maturation and reduce mortality in preterm babies but can trigger adverse effects on the cardiovascular system. The mechanisms underlying off‐target effects of the synthetic glucocorticoids mostly used, Dexamethasone (Dex) and Betamethasone (Beta), are unknown. We investigated effects of Dex and Beta on cardiovascular structure and function, and underlying molecular mechanism using the chicken embryo, an established model system to isolate effects of therapy on the developing heart and vasculature, independent of effects on the mother or placenta. Fertilized eggs were treated with Dex (0.1 mg kg −1 ), Beta (0.1 mg kg −1 ), or water vehicle (Control) on embryonic day 14 (E14, term = 21 days). At E19, biometry, cardiovascular function, stereological, and molecular analyses were determined. Both glucocorticoids promoted growth restriction, with Beta being more severe. Beta compared with Dex induced greater cardiac diastolic dysfunction and also impaired systolic function. While Dex triggered cardiomyocyte hypertrophy, Beta promoted a decrease in cardiomyocyte number. Molecular changes of Dex on the developing heart included oxidative stress, activation of p38, and cleaved caspase 3. In contrast, impaired GR downregulation, activation of p53, p16, and MKK3 coupled with CDK2 transcriptional repression linked the effects of Beta on cardiomyocyte senescence. Beta but not Dex impaired NO‐dependent relaxation of peripheral resistance arteries. Beta diminished contractile responses to potassium and phenylephrine, but Dex enhanced peripheral constrictor reactivity to endothelin‐1. We conclude that Dex and Beta have direct differential detrimental effects on the developing cardiovascular system.


  • Open Access

    Altered Cardiovascular Defense to Hypotensive Stress in the Chronically Hypoxic Fetus

    by Beth J. Allison, Kirsty L. Brain, Youguo Niu, Andrew D. Kane, Emilio A. Herrera, Avnesh S. Thakor, Kimberley J. Botting, Christine M. Cross, Nozomi Itani, Caroline J. Shaw, et al.

    The hypoxic fetus is at greater risk of cardiovascular demise during a challenge, but the reasons behind this are unknown. Clinically, progress has been hampered by the inability to study the human fetus non-invasively for long period of gestation. Using experimental animals, there has also been an inability to induce gestational hypoxia while recording fetal cardiovascular function as the hypoxic pregnancy is occurring. We use novel technology in sheep pregnancy that combines induction of controlled chronic hypoxia with simultaneous, wireless recording of blood pressure and blood flow signals from the fetus. Here, we investigated the cardiovascular defense of the hypoxic fetus to superimposed acute hypotension. Pregnant ewes carrying singleton fetuses surgically prepared with catheters and flow probes were randomly exposed to normoxia or chronic hypoxia from 121±1 days of gestation (term ≈145 days). After 10 days of exposure, fetuses were subjected to acute hypotension via fetal nitroprusside intravenous infusion. Underlying in vivo mechanisms were explored by (1) analyzing fetal cardiac and peripheral vasomotor baroreflex function; (2) measuring the fetal plasma catecholamines; and (3) establishing fetal femoral vasoconstrictor responses to the α 1 -adrenergic agonist phenylephrine. Relative to controls, chronically hypoxic fetal sheep had reversed cardiac and impaired vasomotor baroreflex function, despite similar noradrenaline and greater adrenaline increments in plasma during hypotension. Chronic hypoxia markedly diminished the fetal vasopressor responses to phenylephrine. Therefore, we show that the chronically hypoxic fetus displays markedly different cardiovascular responses to acute hypotension, providing in vivo evidence of mechanisms linking its greater susceptibility to superimposed stress.


  • Open Access

    Embryonic cardioprotection by hydrogen sulphide: studies of isolated cardiac function and ischaemia‐reperfusion injury in the chicken embryo

    by Rita M. Hess, Youguo Niu, Tessa A. C. Garrud, Kimberley J. Botting, Sage G. Ford, Dino A. Giussani

    Key points: In mammals, pregnancy complications can trigger an embryonic or fetal origin of cardiac dysfunction. However, underlying mechanisms remain uncertain because the partial contributions of the challenge on the mother, placenta or offspring are difficult to disentangle. The avian embryo permits isolation of the direct effects of suboptimal conditions during development on the cardiac function of the offspring, independent of additional effects on the mother and/or the placenta. Therefore, the objectives of this work were to adapt the isolated Langendorff technique using the chicken embryo to study the physiology of the developing heart. Here, we introduce a novel technique and show the utility of the technique for exploring cardioprotective roles of H2S in the chicken embryo heart. This work lays the foundation for studying the direct effects of H2S therapy on the embryonic heart independent of effects on the mother and the placenta in adverse development. This study adapted the isolated Langendorff preparation to study the chicken embryo heart in response to ischaemia‐reperfusion (IR) injury. The utility of the technique was tested by investigating cardioprotective effects of hydrogen sulphide (H2S) and underlying mechanisms. Embryonic hearts (19 out of 21 days of incubation) mounted on a Langendorff preparation were exposed to IR (30 min ischaemia) after 4 treatments administered randomly, all as a 1 mm bolus, into the perfusate: saline vehicle (control); sodium hydrogen sulphide (NaHS); NaHS plus glibenclamide, an antagonist of KATP opening (NaHS Glib), and Glib alone (Glib). Relative to controls, NaHS treatment improved cardiac function after ischaemia (mean ± SD for area under the curve, AUC, for left ventricular developed pressure, LVDP: 1767.3 ± 929.5 vs. 492.7 ± 308.1; myocardial contractility, dP/dtmax: 2748.9 ± 1514.9 vs. 763.7 ± 433.1) and decreased infarct size (22.7 ± 8.0 vs. 43.9 ± 4.2%) and cardiac damage (% change in creatinine kinase, 49.3 ± 41.3 vs. 214.6 ± 155.1; all P < 0.05). Beneficial effects of NaHS were blocked by Glib. Glib alone had no effects. NaHS increased coronary flow rate (CFR) during baseline (mean ± SD for AUC: 134.3 ± 91.6 vs. 92.2 ± 35.8) and post IR (1467 ± 529.5 vs. 748.0 ± 222.1; both P < 0.05). However, this effect was not prevented by Glib. Therefore, the chicken embryo heart is amenable for study via the Langendorff preparation under basal conditions and during IR. The data show that H2S confers embryonic cardiac protection via opening of myocardial KATP channels and not via increasing CFR. H2S may prove a useful therapeutic agent to protect the human fetal heart against IR injury, as may occur in complicated labour.